| dc.contributor.advisor | 冷則剛 | zh_TW |
| dc.contributor.author (Authors) | 施乃維 | zh_TW |
| dc.contributor.author (Authors) | Shih,Nai-Wei | en_US |
| dc.creator (作者) | 施乃維 | zh_TW |
| dc.creator (作者) | Shih,Nai-Wei | en_US |
| dc.date (日期) | 2006 | en_US |
| dc.date.accessioned | 14-Sep-2009 09:46:53 (UTC+8) | - |
| dc.date.available | 14-Sep-2009 09:46:53 (UTC+8) | - |
| dc.date.issued (上傳時間) | 14-Sep-2009 09:46:53 (UTC+8) | - |
| dc.identifier (Other Identifiers) | G0092933021 | en_US |
| dc.identifier.uri (URI) | https://nccur.lib.nccu.edu.tw/handle/140.119/31313 | - |
| dc.description (描述) | 碩士 | zh_TW |
| dc.description (描述) | 國立政治大學 | zh_TW |
| dc.description (描述) | 國際經營管理碩士班(IMBA) | zh_TW |
| dc.description (描述) | 92933021 | zh_TW |
| dc.description (描述) | 95 | zh_TW |
| dc.description.abstract (摘要) | 外商與中國製藥產業：市場進入策略與永續培訓 | zh_TW |
| dc.description.abstract (摘要) | 1 INTRODUCTION…………………………………………………………….…1 1.1 PURPOSE OF THE RESEARCH…………………………………………………………..2 1.2 MAIN THEMES…………………………………………………………………………….2 1.3 ANALYTICAL FRAMEWORK & CHAPTER ARRANGEMENTS…………….………..3 1.4 LITERATURE REVIEW……………………………………………………………………4 2 GENERAL HISTORY AND DEVELOPMENT OF THE PHARMACEUTICAL INDUSTRY AROUND THE WORLD…………….11 2.1 HISTORY………………………………………………………….......................................11 2.2 OVERVIEW OF THE INDUSTRY……………………………..………………………….12 2.3 INDUSTRY ANALYSIS AND INDUSTRY REVENUES....................................................14 2.4 INDUSTRY PROSPECTS AND OVERALL ATTRACTIVENESS……………………….18 2.5 PATENTS AND GENERICS………………………………….…………………………….19 2.6 SALES AND MARKETING AND ADVERTISING TO PHYSICIANS…………………...19 3 THE HISTORY AND DEVELOPMENT OF THE PHARMACEUTICAL INDUSTRY IN CHINA………..….………………………………………..22 3.1 OVERVIEW OF CHINESE PHARMACEUTICAL INDUSTRY……………..….................22 3.2 NUMBER, SIZE, AND GROWTH ………………………………………..…………………24 3.3 PRODUCTION LEVELS………………………………………………..................................25 3.4 DOMESTIC PHARMACEUTICAL COMPANIES AND LOW R&D……………………….25 3.5 COMPARISON OF CHINESE AND WESTERN PHARMA BUSINESS……..................….28 3.6 FOREIGN COMPANY MANAGEMENT, FOREIGN COMPANIES, PRODUCTION AND R&D……………………………………………………………………………………..29 3.7 REGULATORY REQUIREMENTS AND GMP COMPLIANCE CERTIFICATION………..42 3.8 GOVERNMENT DRUG PRICING POLICY AND CENTRALIZED TENDERING DRUG PROCUREMENT PROGRAM…………………………………………......………...42 3.9 COMPARISON OF REGULATORY REQUIREMENTS WITH OTHER COUNTRIES…....43 3.10 PATENTS OVERVIEW AND INTELLECTUAL PROBLEMS IN CHINA ……...………...43 4 PHARMACEUTICAL TRAINING AND DEVELOPMENT IN CHINA ..…50 4.1 MEDICAL REPRESENTATIVES HIRING, TRAINING AND DEVELOPMENT……...…...50 4.2 AREA MANAGER TRAINING AND DEVELOPMENT………………………...….……….52 4.3 TRAINER TRAINING AND DEVELOPMENT……………………………..…….…….…...53 4.4 EMERGENCY TRAINING………………..……………….………………………...…….….53 4.5 EXPECTATION AND SUSTAINABILITY…………………………...…….…….……….….54 4.6 CONTINUOUS TRAINING/SUSTAINABILITY ACROSS CHINA……………….…….….54 5 CONCLUSIONS …………………………………………………………..…....56 REFERENCES…………………………………………………………………..….61 | - |
| dc.description.tableofcontents | 1 INTRODUCTION…………………………………………………………….…1 1.1 PURPOSE OF THE RESEARCH…………………………………………………………..2 1.2 MAIN THEMES…………………………………………………………………………….2 1.3 ANALYTICAL FRAMEWORK & CHAPTER ARRANGEMENTS…………….………..3 1.4 LITERATURE REVIEW……………………………………………………………………4 2 GENERAL HISTORY AND DEVELOPMENT OF THE PHARMACEUTICAL INDUSTRY AROUND THE WORLD…………….11 2.1 HISTORY………………………………………………………….......................................11 2.2 OVERVIEW OF THE INDUSTRY……………………………..………………………….12 2.3 INDUSTRY ANALYSIS AND INDUSTRY REVENUES....................................................14 2.4 INDUSTRY PROSPECTS AND OVERALL ATTRACTIVENESS……………………….18 2.5 PATENTS AND GENERICS………………………………….…………………………….19 2.6 SALES AND MARKETING AND ADVERTISING TO PHYSICIANS…………………...19 3 THE HISTORY AND DEVELOPMENT OF THE PHARMACEUTICAL INDUSTRY IN CHINA………..….………………………………………..22 3.1 OVERVIEW OF CHINESE PHARMACEUTICAL INDUSTRY……………..….................22 3.2 NUMBER, SIZE, AND GROWTH ………………………………………..…………………24 3.3 PRODUCTION LEVELS………………………………………………..................................25 3.4 DOMESTIC PHARMACEUTICAL COMPANIES AND LOW R&D……………………….25 3.5 COMPARISON OF CHINESE AND WESTERN PHARMA BUSINESS……..................….28 3.6 FOREIGN COMPANY MANAGEMENT, FOREIGN COMPANIES, PRODUCTION AND R&D……………………………………………………………………………………..29 3.7 REGULATORY REQUIREMENTS AND GMP COMPLIANCE CERTIFICATION………..42 3.8 GOVERNMENT DRUG PRICING POLICY AND CENTRALIZED TENDERING DRUG PROCUREMENT PROGRAM…………………………………………......………...42 3.9 COMPARISON OF REGULATORY REQUIREMENTS WITH OTHER COUNTRIES…....43 3.10 PATENTS OVERVIEW AND INTELLECTUAL PROBLEMS IN CHINA ……...………...43 4 PHARMACEUTICAL TRAINING AND DEVELOPMENT IN CHINA ..…50 4.1 MEDICAL REPRESENTATIVES HIRING, TRAINING AND DEVELOPMENT……...…...50 4.2 AREA MANAGER TRAINING AND DEVELOPMENT………………………...….……….52 4.3 TRAINER TRAINING AND DEVELOPMENT……………………………..…….…….…...53 4.4 EMERGENCY TRAINING………………..……………….………………………...…….….53 4.5 EXPECTATION AND SUSTAINABILITY…………………………...…….…….……….….54 4.6 CONTINUOUS TRAINING/SUSTAINABILITY ACROSS CHINA……………….…….….54 5 CONCLUSIONS …………………………………………………………..…....56 REFERENCES…………………………………………………………………..….61 | zh_TW |
| dc.language.iso | en_US | - |
| dc.source.uri (資料來源) | http://thesis.lib.nccu.edu.tw/record/#G0092933021 | en_US |
| dc.subject (關鍵詞) | 永續培訓 | zh_TW |
| dc.subject (關鍵詞) | 策略 | zh_TW |
| dc.subject (關鍵詞) | 外商 | zh_TW |
| dc.title (題名) | 外商與中國製藥產業：市場進入策略與永續培訓 | zh_TW |
| dc.title (題名) | Entering the Pharmaceutical Industry in China:Market Entry Strategies and Sustainable Training for Foreign Firms | en_US |
| dc.type (資料類型) | thesis | en |
| dc.relation.reference (參考文獻) | ACHEMASIA Trend Report No.2: China`s pharmaceutical industry "Rapid growth in pharmaceuticals" http://www.achemasia.de/data/achemasia_/trend_report_2_e.htm | zh_TW |
| dc.relation.reference (參考文獻) | Bayer China http://www.bayer.com.cn/ | zh_TW |
| dc.relation.reference (參考文獻) | BEST PRACTICES, LLC "Pharmaceutical Sales Training: Turning New Hires into Top Performers" 2007 http://www3.best-in-class.com/bestp/domrep.nsf/Content/F1DEFF19A7B5F1718525718F0078C863!OpenDocument | zh_TW |
| dc.relation.reference (參考文獻) | Bharat Book Bureau. "World Pharmaceutical Market (2007)" 2006 http://www.bharatbook.com/bookdetail.asp?bookid=24220&publisher | zh_TW |
| dc.relation.reference (參考文獻) | Biocompare. "First-Year Sales Training Critical To Success Of Pharmaceutical Reps" January 2007 http://news.biocompare.com/newsstory.asp?id=166625 | zh_TW |
| dc.relation.reference (參考文獻) | Bitpipe. "Pharmaceutical Industry" 2007 http://www.bitpipe.com/rlist/term/Pharmaceutical-Industry.html | zh_TW |
| dc.relation.reference (參考文獻) | Business Link. “Joint Ventures and Partnering” http://www.businesslink.gov.uk/bdotg/action/detail?r.l1=1074404796&r.l3=1073864682&r.t=RESOURCES&type=RESOURCES&itemId=1075411648&r.i=1075411671&r.l2=1074404799&r.s=sc | zh_TW |
| dc.relation.reference (參考文獻) | California State University Stanislaus "Pharmaceutical Industry" http://web.csustan.edu/manage/harris/industry1.html | zh_TW |
| dc.relation.reference (參考文獻) | ChinaVentureNews "Warburg & CITIC Funds China Pharmaceuticals" November 9, 2005 http://www.chinaventurenews.com/50226711/warburg_citic_funds_china_pharmaceuticals.php | zh_TW |
| dc.relation.reference (參考文獻) | Cockburn R et al. “The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers” PLoS Medicine Vol. 2 Issue 4, April 2005 | zh_TW |
| dc.relation.reference (參考文獻) | Ebisch R. "Prescription for change" Teradata March 2005 http://www.teradata.com/t/page/131951/index.html | zh_TW |
| dc.relation.reference (參考文獻) | Eisai. "Major Milestones" http://www.eisai.com/timeline.asp?ID=142 | zh_TW |
| dc.relation.reference (參考文獻) | Forbes.com. "Bayer Expands China Presence" October 26, 2006 | zh_TW |
| dc.relation.reference (參考文獻) | http://www.forbes.com/markets/2006/10/26/bayer-topsun-science-markets-equity-cx_as_1026markets17.html | zh_TW |
| dc.relation.reference (參考文獻) | FriedlNet. "Analysis : The Chinese Pharmaceutical Industry" March 24, 2003 http://www.friedlnet.com/news/02112306.html | zh_TW |
| dc.relation.reference (參考文獻) | GIIChinese.com.tw "Pharmaceutical Sales Training Groups - Building Better Sales Forces" December, 2006 http://www.giichinese.com.tw/chinese/cei46279-pharma-sales.html | zh_TW |
| dc.relation.reference (參考文獻) | Gong Y. “Pharma Moves Ahead Cautiously in China”. Science Vol. 309 29th July 2005 page 735 http://www.sciencemag.org/cgi/content/summary/309/5735/735?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=Pharma+Moves+Ahead+Cautiously+in+China&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT | zh_TW |
| dc.relation.reference (參考文獻) | Herper M. "World`s 10 Best-Selling Drugs" WIRED NEWS. March 28, 2006 http://www.wired.com/news/technology/1,70508-0.html | zh_TW |
| dc.relation.reference (參考文獻) | Horsten J & Van Cauterenleerstoel IR “Janssen China: Case Study Opportunities for SME’s in China” Horsten International November 2006 http://www.horsten.be/index_files/home.htm | zh_TW |
| dc.relation.reference (參考文獻) | IMS. "IMS Reports 11.5 Percent Dollar Growth in `03 U.S. Prescription Sales " February 17, 2004 http://www.imshealth.com/ims/portal/front/articleC/0,2777,6599_3665_44771558,00.html | zh_TW |
| dc.relation.reference (參考文獻) | Liu X. et al. “Drug policy in China. Transformations, current status and future prospects.” Pharmacoeconomics 1997 Jul;12(1):1-9 | zh_TW |
| dc.relation.reference (參考文獻) | Malvern. "Pharmaceutical Industry Overview " 2007 http://www.malvern.co.uk/ProcessEng/industries/pharma/overview.htm | zh_TW |
| dc.relation.reference (參考文獻) | Market Research Centre and the Canadian Trade Commissioner Service. “The Biotechnology Market in China”. November 2001. http://ats.agr.ca/asia/e3254.htm | zh_TW |
| dc.relation.reference (參考文獻) | Market Research.com. "China`s Pharmaceutical Industry: Growth Prospects" August 1998 http://www.marketresearch.com/browse.asp?categoryid=179&sortby=d&g=1&page=10 | zh_TW |
| dc.relation.reference (參考文獻) | Moynihan et al. “Selling sickness: the pharmaceutical industry and disease mongering” BMJ. 2002 Apr 13;324(7342): 886-91 | zh_TW |
| dc.relation.reference (參考文獻) | Myers K. “Marketing to Professionals: Tomorrow`s Changes Today” January 2007 http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=395598 | zh_TW |
| dc.relation.reference (參考文獻) | NBET. "Antitrust Enforcement In Pharmaceutical Industry Mergers" January 2003 http://jobfunctions.bnet.com/whitepaper.aspx?docid=78634 | zh_TW |
| dc.relation.reference (參考文獻) | Novartis China http://www.novartis.com.cn/ | zh_TW |
| dc.relation.reference (參考文獻) | Parry J. “Drug company pulls out of Chinese lawsuit over diabetes drug.” BMJ. 2004 Aug 28;329(7464):476. | zh_TW |
| dc.relation.reference (參考文獻) | Pfizer China http://www.pfizer.com.cn/ | zh_TW |
| dc.relation.reference (參考文獻) | Piribo. "Business Opportunities in China The Impact of the WTO" March 2006 http://www.piribo.com/publications/country/asia_pacific/china/business_opportunities_china.html | zh_TW |
| dc.relation.reference (參考文獻) | PWC. "China: Prescription for growth" http://www.pwc.com/extweb/pwcpublications.nsf/docid/2992C71A5CA9BE1285256F5000662664 | zh_TW |
| dc.relation.reference (參考文獻) | Ramsurun J. “Profile Changing China” China Healthcare Consulting September 2002 pg. 265-269 http://www.chccgroup.com/Archive/PPR%20China%20doc.pdf | zh_TW |
| dc.relation.reference (參考文獻) | REDORBIT "The Impact of China`s Fast Growing Pharmaceutical Industry" February 6, 2006 http://www.redorbit.com/news/display/?id=381333 | zh_TW |
| dc.relation.reference (參考文獻) | Reed Elsevier "Reed Exhibitions and Sinopharm agree joint venture" August 29, 2005 http://www.reed-elsevier.com/index.cfm?Articleid=1445 | zh_TW |
| dc.relation.reference (參考文獻) | Robinson JT. “Changing the Face of Detailing by Motivating Physicians to See Pharmaceutical Sales Reps” November 2003 http://www.healthbanks.com/PatientPortal/Public/support_documents/PMT_Robinson.pdf | zh_TW |
| dc.relation.reference (參考文獻) | SHAANXI ASSOCIATION OF ENTERPRISES WITH FOREIGN INVESTMENT. "The Largest Joint-Venture Pharmaceutical Enterprise in China" September 14, 2006 http://saefi.sxdofcom.gov.cn/2006/9-14/15281884521.asp | zh_TW |
| dc.relation.reference (參考文獻) | Shijiazhuang Pharmaceutical Group Co.,Ltd http://www.e-cspc.com/english/ | zh_TW |
| dc.relation.reference (參考文獻) | Smith A. "Pfizer to cut 10,000 jobs, shut 5 plants" CNNMoney.com January 22, 2007 http://money.cnn.com/2007/01/22/news/companies/pfizer/index.htm?postversion=2007012216 | zh_TW |
| dc.relation.reference (參考文獻) | Sommerville Q. “China tightens net on fake drugs” BBC News, Shanghai. February 9, 2007 http://news.bbc.co.uk/2/hi/asia-pacific/6345165.stm | zh_TW |
| dc.relation.reference (參考文獻) | State Intellectual Property Office of P.R.C. "White Paper on the Intellectual Property Rights Protection in China in 1998" March 6, 2002 http://www.sipo.gov.cn/sipo_English/ndbg/bps/200203/t20020306_33981.htm | zh_TW |
| dc.relation.reference (參考文獻) | Stone R & Xin H. “CHINESE DRUG RESEARCH: Novartis Invests $100 Million in Shanghai” Science November 17, 2006: Vol. 314. no. 5802, pp. 1064 – 1065 http://www.sciencemag.org/cgi/content/full/314/5802/1064b | zh_TW |
| dc.relation.reference (參考文獻) | Takeda China http://www.takeda.com/worldwide/cn/index.html | zh_TW |
| dc.relation.reference (參考文獻) | The Economist "Joint ventures in China Wahaha-haha!" April 19, 2007 http://www.economist.com/business/displaystory.cfm?story_id=9040416 | zh_TW |
| dc.relation.reference (參考文獻) | Tomlinson R. “China cracks down on counterfeit medicines.” BMJ. 1999 Mar 6;318(7184):624. | zh_TW |
| dc.relation.reference (參考文獻) | Trombetta B. "2005 Industry Audit " PharmExec.com September 1, 2005. http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=177964 | zh_TW |
| dc.relation.reference (參考文獻) | Vanhonacker WR. "GSB ChinaWISE 2005: When good guanxi turns bad " UCT Graduate School of Business Newsline 2006 http://www.gsb.uct.ac.za/newsletter/newsletterArticle.ASP?intArticleID=878 | zh_TW |
| dc.relation.reference (參考文獻) | Wang MW et al. “China Evolves from Imitation to Innovation”. Drug Discovery & Development. 2005 http://www.dddmag.com/ShowPR.aspx?PUBCODE=016&ACCT=1600000100&ISSUE=0506&RELTYPE=PR&ORIGRELTYPE=RR&PRODCODE=00000000&PRODLETT=A | zh_TW |
| dc.relation.reference (參考文獻) | Wang YR. “Price competition in the Chinese pharmaceutical market.” Int J Health Care Finance Econ. 2006 Jun; 6(2):119-29. | zh_TW |
| dc.relation.reference (參考文獻) | Weinstein M. “Satellite Success: Is IDL Right for You?” Training January/February 2007 page 36 | zh_TW |
| dc.relation.reference (參考文獻) | Wen T. “Growing with China, the Bayer way” China Business Weekly. May 16-22, 2005 page 7 | zh_TW |
| dc.relation.reference (參考文獻) | Wikipedia “Joint Venture” 2007 | zh_TW |
| dc.relation.reference (參考文獻) | http://en.wikipedia.org/wiki/Joint_ventures | zh_TW |
| dc.relation.reference (參考文獻) | Wikipedia “Pharmaceutical Company” 2006 http://en.wikipedia.org/wiki/Pharmaceutical_company | zh_TW |
| dc.relation.reference (參考文獻) | Wikipedia “Pharmaceuticals in China” 2007 http://en.wikipedia.org/wiki/Pharmaceuticals_%28China%29 | zh_TW |
| dc.relation.reference (參考文獻) | Xinhua-PRNewswire. "Sinovac Biotech Ltd. Begins Pandemic Flu (H5N1) Vaccine Clinical Trials " December 21, 2005 http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/12-21-2005/0004237948&EDATE | zh_TW |
| dc.relation.reference (參考文獻) | Yangtze River Pharmacy Group http://www.yangtzeriver.com/english/index.htm | zh_TW |
| dc.relation.reference (參考文獻) | Young LW. "Protection of Pharmaceuticals in China" September 1999 http://www.wangandwang.com/pharmic.htm | zh_TW |
| dc.relation.reference (參考文獻) | “薄利多銷” Acme Translation Co.,Ltd http://www.paper-translation.com/words/b9.html | zh_TW |
